Lymphoma

The Pharmacy Times® Lymphoma Resource Center is a comprehensive resource for clinical news and expert insights on treatments for lymphoma, a cancer that begins in cells of the lymph system. Common treatments for lymphoma may involve chemotherapy, medication, radiation therapy, and stem cell transplant.

Latest News

Dual-Targeted Therapy With Ruxolitinib and Duvelisib: Optimizing Treatment for T-Cell Lymphomas Through Pharmacist Collaboration
Dual-Targeted Therapy With Ruxolitinib and Duvelisib: Optimizing Treatment for T-Cell Lymphomas Through Pharmacist Collaboration

December 16th 2024

Alison Moskowitz, MD, discusses the clinical considerations, dosing strategies, and the critical role of pharmacists in managing toxicities and tailoring treatment plans for dual-targeted therapy with ruxolitinib and duvelisib.

Ketogenic Diet and β-Hydroxybutyrate May Enhance CAR T-Cell Therapy Efficacy
Ketogenic Diet and β-Hydroxybutyrate May Enhance CAR T-Cell Therapy Efficacy

December 7th 2024

From Dogs to Human: AI-Powered Drug Response Prediction Technology Shows Improved Clinical Outcomes in Oncology
From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

December 2nd 2024

Lisocabtagene Maraleucel: A Review of Indications
Lisocabtagene Maraleucel: A Review of Indications

November 27th 2024

Lymphoma, Rituximab, Biosimilar, Hematology | Image Credit: ©freshidea | stock.adobe.com
Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events

November 21st 2024

Video Interviews
Podcasts
Latest CME Events & Activities

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care

1.0 Credits / Hematologic Cancer, Oncology

View More

Revolutionizing Multiple Myeloma Care: CAR T-Cell Therapy, Bispecific Antibodies, and Patient-Centered Strateg...

1.0 Credit / Oncology, Hematologic Cancer

View More

Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists

1.0 Credit / Hematologic Cancer, Oncology

View More

Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise

1.0 Credit / Hematologic Cancer, Oncology

View More

Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: ...

1.0 Credit / Hematologic Cancer

View More

Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and...

1.0 Credit / Hematologic Cancer

View More

Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based C...

1.0 Credit / Hematologic Cancer, Oncology

View More

Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operati...

1.0 Credit / Hematologic Cancer, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes: Bridging Clinical Innovation and Pract...

1.0 Credit / Hematologic Cancer, Oncology

View More

Finding Balance Between Advancement and Application: A Guide for Community Oncology Pharmacists on CAR T-Cell ...

0.75 Credit / Oncology, Hematologic Cancer

View More

Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodi...

1.5 Credits / Oncology, Hematology, Hematologic Cancer

View More

Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Manage...

1.5 Credits / Hematology, Hematologic Cancer, Oncology

View More

Navigating Long-Term Toxicities of CAR T-Cell Therapy: Educational Insights for Oncology Pharmacists

1.25 Credits / Oncology, Hematologic Cancer

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Overcoming Disparities in Multiple Myeloma Treatment: Empowering Pharmacists to Drive Change

1.0 Credit / Health Equity, Diversity & Inclusion, Hematologic Cancer, Hematology, Oncology

View More

Navigating Treatment Evolution in Myelofibrosis: Oncology Pharmacist's Strategies for JAK Inhibitor Optimizati...

1.0 Credit / Hematologic Cancer, Hematology, Oncology

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatme...

1.0 Credit / Hematologic Cancer, Oncology

View More

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

1.0 Credit / Hematologic Cancer

View More

Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management

1.0 Credit / Hematologic Cancer, Lung Cancer, Oncology

View More

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic L...

1.0 Credit / Hematologic Cancer, Oncology

View More

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology

View More

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

1.5 Credits / Hematologic Cancer, Hematology, Oncology

View More

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

1.0 Credit / Hematologic Cancer, Oncology

View More

More News